Baxter International Inc/ US0718131099 /
7/11/2024 10:10:00 PM | Chg. +0.97 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
35.22USD | +2.83% | 4.24 mill. Turnover: 124.49 mill. |
34.23Bid Size: 100 | 35.44Ask Size: 800 | 17.89 bill.USD | 3.29% | 6.71 |
GlobeNewswire
6/26
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire
6/20
ProvisionAi COO Terri Bennett Robbins Named One of 20 Women Reshaping the Future of Logistics and th...
GlobeNewswire
6/20
E-fuels offer long-term solution to key energy transition transport sectors, but journey needs to st...
GlobeNewswire
6/14
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
6/12
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
6/12
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
5/16
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
5/15
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...